Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Am J Manag Care Retrieve available abstracts of 50 articles: HTML format

Single Articles

May 2024
1. POONAWALLA IB, Chung L, Shetler S, Pearce H, et al
   Medication adherence star ratings measures, health care resource utilization, and cost.
   Am J Manag Care. 2024;30:210-217.
   PubMed     Abstract available
   
   
   April 2024
2. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
   Medication persistence and its impact on type 2 diabetes.
   Am J Manag Care. 2024;30:e124-e134.
   PubMed     Abstract available
   
   
   
3. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
   Institutional practices for charitable medication access for uninsured patients.
   Am J Manag Care. 2024;30:e135-e139.
   PubMed     Abstract available
   
   
   March 2024
4. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
   Improving glycemic control in diabetes through virtual interdisciplinary rounds.
   Am J Manag Care. 2024;30:e78-e84.
   PubMed     Abstract available
   
   
   
5. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
   Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
   Am J Manag Care. 2024;30:107-108.
   PubMed     Abstract available
   
   
   
6. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
   At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
   Am J Manag Care. 2024;30:e73-e77.
   PubMed     Abstract available
   
   
   
7. LO JC, Chandra M, Yang W, Thompson N, et al
   Challenges of fracture risk assessment in Asian and Black women.
   Am J Manag Care. 2024;30:140-144.
   PubMed     Abstract available
   
   
   December 2023
8. KERR D, Duncan I, Repetto E, Maroun R, et al
   Cost analysis of self-monitoring blood glucose in nonintensively managed type 2 diabetes.
   Am J Manag Care. 2023;29:670-675.
   PubMed     Abstract available
   
   
   
9. LISS DT, Cherupally M, O'Brien MJ, Kang RH, et al
   Treatment modification after initiating second-line medication for type 2 diabetes.
   Am J Manag Care. 2023;29:661-668.
   PubMed     Abstract available
   
   
   November 2023
10. HUGHES J, Sparkman A, Smith P, McCormack T, et al
    Charitable medication distribution improves care for uninsured patients with diabetes.
    Am J Manag Care. 2023;29:573-575.
    PubMed     Abstract available
    
    
    October 2023
11. TRUONG B, Li Y, Zheng J, Qian J, et al
    Use of second-generation antidiabetic medication among a nationally representative sample.
    Am J Manag Care. 2023;29:e307-e316.
    PubMed     Abstract available
    
    
    September 2023
12. RIGGS KR, Presley CA, Agne AA, Howell CR, et al
    Measuring continuity of care for diabetes: which visits to include?
    Am J Manag Care. 2023;29:e274-e279.
    PubMed     Abstract available
    
    
    August 2023
13. YUN J, Filardo G, Ahuja V, Bowen ME, et al
    Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data.
    Am J Manag Care. 2023;29:e229-e234.
    PubMed     Abstract available
    
    
    
14. STOECKER C, Nauman E, Bazzano AN, Price-Haywood EG, et al
    Non-face-to-face care management and service utilization in patients with diabetes.
    Am J Manag Care. 2023;29:417-422.
    PubMed     Abstract available
    
    
    June 2023
15. ZAKERI M, Lewing BD, Contreras J, Sansgiry SS, et al
    Economic burden of nonadherence to standards of diabetes care.
    Am J Manag Care. 2023;29:e176-e183.
    PubMed     Abstract available
    
    
    
16. COLVIN CL, Akinyelure OP, Rajan M, Safford MM, et al
    Diabetes, gaps in care coordination, and preventable adverse events.
    Am J Manag Care. 2023;29:e162-e168.
    PubMed     Abstract available
    
    
    
17. TURK MT, Ritchie ND, Jakub K
    Stakeholder analysis: Medicare Diabetes Prevention Program awareness and implementation.
    Am J Manag Care. 2023;29:308-312.
    PubMed     Abstract available
    
    
    
18. KAMAL KM
    The role of managed care professionals in the management of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    PubMed     Abstract available
    
    
    
19. ALMONY A
    Treatment approaches for neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    PubMed     Abstract available
    
    
    
20. ALMONY A
    Disease burden of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    PubMed     Abstract available
    
    
    April 2023
21. MILLER-ROSALES C, Brewster AL, Shortell SM, Rodriguez HP, et al
    Multilevel influences on patient engagement and chronic care management.
    Am J Manag Care. 2023;29:196-202.
    PubMed     Abstract available
    
    
    February 2023
22. LEWING BD, Wallick C, To TM, Masters H 3rd, et al
    Outcomes of antiviral treatment for influenza in type 2 diabetes.
    Am J Manag Care. 2023;29:e43-e50.
    PubMed     Abstract available
    
    
    January 2023
23. RODRIGUEZ HP, Ciemins EL, Rubio K, Rattelman C, et al
    Health systems and telemedicine adoption for diabetes and hypertension care.
    Am J Manag Care. 2023;29:42-49.
    PubMed     Abstract available
    
    
    December 2022
24. DATAR M, Ramakrishnan S, Chong J, Montgomery E, et al
    A kidney diagnostic's impact on physician decision-making in diabetic kidney disease.
    Am J Manag Care. 2022;28:654-661.
    PubMed     Abstract available
    
    
    
25. KYRILLOS J
    Semaglutide 2.4-mg injection as a novel approach for chronic weight management.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
26. MASSIE DC, Amaro A, Kaplan M
    Patient well-being and the clinical and economic burdens associated with obesity in the United States.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    November 2022
27. OLOMU A, Tikaria R, Kelly-Blake K, Hart-Davidson W, et al
    Type 2 diabetes patient activation and mHealth interventions decreased cardiovascular disease risk.
    Am J Manag Care. 2022;28:e392-e398.
    PubMed     Abstract available
    
    
    
28. RAMACHANDRAN S, Zhang Y, Dunn TJ, Goswami S, et al
    Impact of food affordability on diabetes-related preventable hospitalization.
    Am J Manag Care. 2022;28:574-580.
    PubMed     Abstract available
    
    
    October 2022
29. KARPES MATUSEVICH AR, Xavier C, Rasu RS
    Long-term medication adherence and preventive vs reactive care utilization among older adults with diabetes.
    Am J Manag Care. 2022;28:e378-e387.
    PubMed     Abstract available
    
    
    
30. BAXTER SL, Quackenbush Q, Cerda J, Gregg C, et al
    Implementing clinical informatics tools for primary care-based diabetic retinopathy screening.
    Am J Manag Care. 2022;28:e355-e362.
    PubMed     Abstract available
    
    
    September 2022
31. SHAWAHNA R, Thawabi F, Salah R, Ramadan S, et al
    Pharmaceutical care services for patients with diabetes: a systematic scoping review.
    Am J Manag Care. 2022;28:e339-e346.
    PubMed     Abstract available
    
    
    
32. BELLIGUND P, Attaway A, Lopez R, Damania D, et al
    Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations.
    Am J Manag Care. 2022;28:e325-e332.
    PubMed     Abstract available
    
    
    August 2022
33. IYER NN, Shah S, Ganz ML, Dang-Tan T, et al
    Glucose-lowering treatment patterns in patients with diabetic kidney disease.
    Am J Manag Care. 2022;28:e301-e307.
    PubMed     Abstract available
    
    
    
34. BETTS KA, Song J, Elliott J, Warnock N, et al
    Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
35. POCHOPIEN M, Cherney DZI, Drzewiecka A, Folkerts K, et al
    Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
36. COOK DJ, Cohen K, Deypalan MN
    A data-based foundation for managing hypertension services.
    Am J Manag Care. 2022;28:e282-e288.
    PubMed     Abstract available
    
    
    
37. NAIR R, Meadows E, Sheer R, Lipkovich I, et al
    Activation, physical activity, and outcomes among individuals with T2D.
    Am J Manag Care. 2022;28:374-380.
    PubMed     Abstract available
    
    
    July 2022
38. MCADAM-MARX C
    Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
39. GOLDMAN J
    Continuous glucose monitoring metrics: interpretation and integrations.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
40. UNGER J
    Continuous glucose monitoring overview: features and evidence.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    March 2022
41. KIM JE
    Exploring neovascular age-related macular degeneration and diabetic macular edema and advances in treatment.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
42. LIU Y
    Managed care opportunities and approaches to select treatment for sight preservation.
    Am J Manag Care. 2022;28.
    PubMed     Abstract available
    
    
    
43. SOLBERG LI, Carlin CS, Peterson KA, Eder M, et al
    Diabetes care quality: do large medical groups perform better?
    Am J Manag Care. 2022;28:101-107.
    PubMed     Abstract available
    
    
    December 2021
44. POCHOPIEN MT, Cherney DZI, Folkerts K, Levy P, et al
    FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    PubMed     Abstract available
    
    
    
45. BETTS KA, Song J, Faust E, Yang K, et al
    Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    PubMed     Abstract available
    
    
    
46. FRIED LF, Petruski-Ivleva N, Folkerts K, Schmedt N, et al
    ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease.
    Am J Manag Care. 2021;27.
    PubMed     Abstract available
    
    
    November 2021
47. GRUSS I, Firemark A, Papajorgji-Taylor D, Fitzpatrick SL, et al
    Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.
    Am J Manag Care. 2021;27:e400-e403.
    PubMed     Abstract available
    
    
    
48. MILLER E, Kerr MSD, Roberts GJ, Nabutovsky Y, et al
    Flash CGM associated with event reduction in nonintensive diabetes therapy.
    Am J Manag Care. 2021;27:e372-e377.
    PubMed     Abstract available
    
    
    October 2021
49. ZUPA MF, Piette JD, Stoll SC, Obrosky DS, et al
    Patient and supporter factors affecting engagement with diabetes telehealth.
    Am J Manag Care. 2021;27:409-414.
    PubMed     Abstract available
    
    
    
50. PANDYA N, Trenery A, Sieradzan R, Gabai C, et al
    Hypoglycemia upon hospital admission from long-term care: health care resource use.
    Am J Manag Care. 2021;27:e349-e354.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.